Results 41 to 50 of about 1,610 (149)

Effective correction of genitourinary menopausal syndrome by the method of fractional laser ablation [PDF]

open access: yesРМЖ. Мать и дитя, 2018
Effective correction of genitourinary menopausal syndrome by the method of fractional laser ablation Dobrokhotova Yu.E., Ilyina I.Yu., Venediktova M.G., Utina M.S., Morozova K.V., Suvorova V.A., Vasilyeva A.S.
Yu.E. Dobrokhotova   +6 more
doaj  

The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause

open access: yesClimacteric, 2018
Objectives: The primary objective of the European Vulvovaginal Epidemiological Survey (EVES) was to assess, at a country level, the prevalence of postmenopausal women with vulvovaginal atrophy (VVA) confirmed by gynecological clinical assessment among all postmenopausal women attending menopause centers.
S. Palacios   +4 more
openaire   +3 more sources

Evaluation of cervical screening at treatment of a vulvovaginal atrophy in periand postmenopausal women [PDF]

open access: yesГинекология, 2016
Objective. Determination of effective application of vaginal complex estriol 0,2 mg/progesteron 2 mg/Lactobacillus casei rhamnosus 2¥109 at women with a vulvovaginal atrophy in peri-and postmenopausal women with a evaluation of cervical screening ...
T V Klinyshkova   +2 more
doaj  

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy

open access: yesInternational Journal of Women's Health, 2009
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, S Kellogg, M Krychman
doaj  

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

open access: yesMedical Devices: Evidence and Research, 2020
Aino Fianu Jonasson,1 Marie Bixo,2 Inger Sundström Poromaa,3 Mikael Åstrom4 1Department of Clinical Sciences, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institute, Stockholm, Sweden; 2Department of Clinical ...
Fianu Jonasson A   +3 more
doaj  

Efficacy and safety of ultra-low-dose Vagifem (10 mcg)

open access: yesPatient Preference and Adherence, 2011
Janet A Chollet1,2 1Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Pear Tree Pharmaceuticals, Waltham, MA, USA Abstract: Vulvovaginal atrophy [VVA] is defined as inflammation of the vaginal epithelium due to atrophy secondary to decreased levels
Chollet JA
doaj  

Vaginal LASER and estrogen comparison in Genitourinary Syndrome of Menopause

open access: yesContinence
Aim:: This study aims to compare the efficacy of CO2 fractionated laser therapy and topical estrogen treatment in managing Genitourinary Syndrome of Menopause (GSM).
Aytaj Jafarzade   +3 more
doaj   +1 more source

Dyspareunia in women in preand postmenopausal period [PDF]

open access: yesГинекология, 2016
The article presents current views on the multiple pathogenetic mechanisms of development of dyspareunia in women in pre - and postmenopausal women with positions of biopsychosocial approach.
A I Fedorova
doaj  

Barriers to effective treatment of vaginal atrophy with local estrogen therapy

open access: yesInternational Journal of General Medicine, 2013
Suzanne ReiterMid-County Health Center, Largo, FL, USAAbstract: Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary
Reiter S
doaj  

Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats. [PDF]

open access: yesFront Endocrinol (Lausanne), 2023
Ismail NH   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy